Mini reviewPublished 30 Jul 2024
Interleukin-6 as a Biomarker for Chronic Inflammatory Diseases: A Comprehensive Review
Faculty of Medicine, Alexandria University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Interleukin-6 (IL-6) is a multifunctional cytokine involved in immune regulation, inflammation, and hematopoiesis. Elevated levels of IL-6 are associated with various chronic inflammatory diseases, including rheumatoid arthritis, Crohn’s disease, psoriasis, and cardiovascular diseases. This comprehensive review explores the pathophysiological role of IL-6, its diagnostic utility, and its therapeutic implications. IL-6’s involvement in key signaling pathways and its impact on disease mechanisms are discussed in detail. Additionally, the review highlights the use of IL-6 as a biomarker for disease activity and severity, and the potential of IL-6 inhibitors in improving clinical outcomes. Understanding IL-6’s multifaceted role enhances our ability to diagnose, monitor, and treat chronic inflammatory diseases effectively.
Keywords
- Interleukin-6
- IL-6
- Chronic inflammatory diseases
- Rheumatoid arthritis
- Crohn's disease
- Psoriasis
- Cardiovascular diseases
- Cytokine biomarker
- IL-6 inhibitors
- Inflammation
- Immune regulation
- Pathophysiology
- Diagnostic biomarker
- Therapeutic target
- JAK/STAT pathway
- Acute phase response
- Osteoclastogenesis
- T cell survival
- Keratinocyte proliferation
- Atherosclerosis
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cytokine Biology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Mohammad Radwan”